Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years

Pennell, D. and Porter, J.B. and Cappellini, M.D. and Chan, L.L. and El-Beshlawy, A. and Aydinok, Y. and Ibrahim, H. and Li, Chi-Kong and Viprakasit, V. and Elalfy, M.S. and Kattamis, A. and Smith, G. and Habr, D. and Domokos, G. and Roubert, B. and Taher, A. (2010) Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years. Blood, 116 (21). pp. 1735-1736.

Full text not available from this repository.
Item Type: Article
Additional Information: 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, DEC 04-07, 2010
Subjects: Q Science > Q Science (General)
R Medicine
Depositing User: Mr Faizal 2
Date Deposited: 13 Jan 2015 06:46
Last Modified: 13 Jan 2015 06:46
URI: http://eprints.um.edu.my/id/eprint/11953

Actions (login required)

View Item View Item